Full name
LYMELAB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
LYMELAB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JANA KOCHANOWSKIEGO 49A, 01-864 WARSZAWA
TAX ID1182216403
Rate company:
LYMELAB PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID1182216403
KRS0000870572
Share capital5,000.00 zł
address
UL. JANA KOCHANOWSKIEGO 49A, 01-864 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
1182216403
REGON
387621050
KRS
0000870572
Legal form
limited liability company
Register Address
UL. JANA KOCHANOWSKIEGO 49A, 01-864 WARSZAWA
Date of registration in KRS
2020-11-25
Date of commencement of economic activity
2020-11-25
Act signature
RDF/572913/23/926
Pkd codes
72.11.Z - Research and experimental development on biotechnology
01.28.Z - Growing of spices, aromatic, drug and pharmaceutical crops
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
47.73.Z - Dispensing chemist in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
85.59.B - Other out-of-school forms of education, not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL33 1240 5934 1111 0011 0362 1271 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | ||
|---|---|---|---|
K PLN | K PLN | % | |
Profit (loss) on sale  | -10,7 | -11,8 | -10,5 |
Gross profit (loss) | -1,2 | -11,9 | -861,8 |
EBITDA | -1,2 | -11,9 | -870,7 |
Short time liabilities | 6,3 | 23,9 | 277,8 |
Other operating costs | 0 | 0 | 34,5 |
Equity capital | 3,8 | -8,1 | -315,3 |
Operating profit (EBIT) | -1,2 | -11,9 | -870,7 |
Assets | 10,1 | 15,8 | 56,6 |
Net profit (loss) | -1,2 | -11,9 | -861,8 |
Cash | 9,1 | 13,4 | 47,1 |
Net income from sale | 123,5 | 141,5 | 14,6 |
Liabilities and provisions for liabilities | 6,3 | 23,9 | 277,8 |
Working assets | 9,1 | 14,8 | 62,9 |
Other income costs | 9,5 | 0 | -100 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | -32,8 | 146,4 | 179,2 |
Equity capital to total assets | 37,3 | -51,3 | -88,6 |
Gross profit margin | -1 | -8,4 | -7,4 |
EBITDA Margin | -1 | -8,4 | -7,4 |
Days | Days | Days | |
Short term commitment turnover cycle | 19 | 62 | 43 |
Current financial liquidity indicator | 1.4367784261703491 | 0.6192831993103027 | -0,8 |
Net dept to EBITDA | 7.441469669342041 | 1.127572774887085 | -6,3 |
Financial statements
01-01-2022 - 31-12-2022
Annual financial report
Download xml01-01-2022 - 31-12-2022
Annual financial report
Download xlsx01-01-2022 - 31-12-2022
Resolution on profit distribution or loss coverage
Download pdf01-01-2022 - 31-12-2022
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Molecular Biotech Mateusz Gielata
Warszawa
Michał Ordak Ekspertstat
Warszawa
Wojciech Gładysz SCRA
Piskórka
diagmol Łukasz Łaczmański
Wrocław
JAROSZ BOŻENA
Lublin